Compare CELC & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CELC | VMD |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 280.4M |
| IPO Year | 2017 | N/A |
| Metric | CELC | VMD |
|---|---|---|
| Price | $105.07 | $7.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $100.13 | N/A |
| AVG Volume (30 Days) | ★ 945.1K | 144.4K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.92 |
| EPS | N/A | ★ 0.34 |
| Revenue | N/A | ★ $254,794,000.00 |
| Revenue This Year | N/A | $20.05 |
| Revenue Next Year | N/A | $17.44 |
| P/E Ratio | ★ N/A | $21.26 |
| Revenue Growth | N/A | ★ 18.89 |
| 52 Week Low | $7.58 | $5.93 |
| 52 Week High | $112.64 | $8.93 |
| Indicator | CELC | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 70.65 | 64.67 |
| Support Level | $100.00 | $6.60 |
| Resistance Level | $108.91 | $7.44 |
| Average True Range (ATR) | 5.14 | 0.20 |
| MACD | -0.88 | 0.07 |
| Stochastic Oscillator | 54.47 | 75.60 |
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.